Batifiban contains a structured peptide-derived framework enriched with aromatic and basic residues that affect receptor-binding interactions. Its arrangement supports studies of steric complementarity and solvent accessibility. Researchers examine conformational states to clarify sequence-driven activity. Uses include ligand-design optimization, binding-site mapping, and biochemical mechanism studies.
CAT No: R2503
CAS No:710312-77-9
Synonyms/Alias:Batifiban;Correctin;7AKM76YKN5;UNII-7AKM76YKN5;BAT 2094;BAT-2094;710312-77-9;L-Cysteinamide, N2-(3-mercapto-1-oxopropyl)-L-arginylglycyl-L-alpha-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1->6)-disulfide;L-CYSTEINAMIDE, N2-(3-MERCAPTO-1-OXOPROPYL)-L-ARGINYLGLYCYL-L-.ALPHA.-ASPARTYL-L-TRYPTOPHYL-L-PROLYL-, CYCLIC (1->6)-DISULFIDE;DTXSID701031211;DA-71298;HY-125053;CS-0088845;2-[(3S,6S,12S,20R,23S)-20-carbamoyl-12-[3-(diaminomethylideneamino)propyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,22-hexaoxo-17,18-dithia-1,4,7,10,13,21-hexazabicyclo[21.3.0]hexacosan-6-yl]acetic acid;N5-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-arginylglycyl-L-alpha-aspartyl-L-alpha-trypotophyl-L-alpha-prolyl-L-alpha-cysteinamide,cyclic(1-6)-disulfide;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.